Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: The National Health and Nutrition Examination Survey (NHANES) 2007-2010

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Tilert, Timothy ^a   Dillon, Charles ^a   Paulose Ram, Ryne ^a   Hnizdo, Eva ^b   Doney, Brent ^b  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Bronchodilator; COPD; NHANES; Prevalence; Spirometry

Indexed keywords

BRONCHODILATING AGENT;

ADULT; AGED; ARTICLE; BODY HEIGHT; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EMPHYSEMA; ETHNICITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH CARE SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; PREVALENCE; RACE; RESPIRATORY AIRFLOW; SELF REPORT; SPIROMETRY; UNITED STATES; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; MIDDLE AGED; NUTRITION; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STATISTICS; TREATMENT OUTCOME; VITAL CAPACITY;

ADULT; AGED; BRONCHODILATOR AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TREATMENT OUTCOME; UNITED STATES; VITAL CAPACITY;

EID: 84885049217     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-103     Document Type: Article

References (30)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for the Diagnosis, Management and Prevention of COPD 2013, http://www.goldcopd.org, Global Initiative for Chronic Obstructive Lung Disease (GOLD).
2. Barnes TA, Fromer L. Spirometry use: detection of chronic obstructive pulmonary disease in the primary care setting. Clin Interv Aging 2011, 6:47-52. 3066252, 21472091.
3. American Thoracic Society - European Respiratory Society Standards for the Diagnosis and Management of Patients with COPD http://www.thoracic.org/clinical/copd-guidelines/resources/copddoc.pdf, American Thoracic Society - European Respiratory Society.
4. CDC Chronic obstructive pulmonary disease among adults - United States, 2011. MMWR MMWR 2012, 61:938-943. CDC.
5. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005, 26(5):948-968. 10.1183/09031936.05.00035205, 16264058.
6. Steinacher R, Parissis JT, Strohmer B, Eichinger J, Rottlaender D, Hoppe UC, ltenberger J. Comparison between ATS/ERS age-and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure. Clin Res Cardiol 2012, 101(8):637-645. 10.1007/s00392-012-0438-0, 22395777.
7. Calverley PMA. The GOLD Classification Has Advanced Understanding of COPD. Am J Respir Crit Care Med 2004, 170(3):211-212. 10.1164/rccm.2405008, 15280171.
8. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002, 20(5):1117-1122. 10.1183/09031936.02.00023202, 12449163.
9. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003, 22(2):268-273. 10.1183/09031936.03.00075102, 12952259.
10. Bakke PS, Ronmark E, Eagan TM, Pistelli F, Annesi-Maesano I, Maly M, Meren M, Zielinski J, Viegi G, Lundback B. Recommendations for epidemiological studies on COPD. Eur Respir J 2012, 39(5):1278-1279.
11. National Center for Health Statistics National Health and Nutrition Examination Survey http://www.cdc.gov/nchs/about/major/nhanes/datalink.htm, National Center for Health Statistics.
12. Zipf G, Chiappa M, Porter K, Ostchega Y, Lewis B, Dostal J. The National Health and Nutrition Examination Survey: Plan and Operations, 1999-2010. Vital Health Stat 2013, 1(56):10-22.
13. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999, 159(1):179-87. 10.1164/ajrccm.159.1.9712108, 9872837.
14. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005, 26(2):319-338. 10.1183/09031936.05.00034805, 16055882.
15. NHANES Respiratory Health - Bronchodilator Procedures Manual http://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/Bronchodilator.pdf, NHANES.
16. Hankinson JL, Kawut SM, Shahar E, Smith LJ, Stukovsky KH, Barr RG. Performance of American Thoracic Society-Recommended Spirometry Reference Values in a Multiethnic Sample of AdultsThe Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. CHEST 2010, 137(1):138-145. 10.1378/chest.09-0919, 2803123, 19741060.
17. National Center for Health Statistics NHANES Analytic and Reporting Guidelines http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/nhanes_analytic_guidelines_dec_2005.pdf, National Center for Health Statistics.
18. Wun LM, Ezzati-Rice TM, Diaz-Tena N, Greenblatt J. On modelling response propensity for dwelling unit (DU) level non-response adjustment in the Medical Expenditure Panel Survey (MEPS). Stat Med 2007, 26(8):1875-84. 10.1002/sim.2809, 17206601.
19. Kalton G, Flores-Cervantes I. Weighting methods. Journal of Official Statistics-Stockholm 2003, 19(2):81-98.
20. Potter F, Grau E, Williams S, Diaz-Tena N, Carlson BL. An application of propensity modeling: Comparing unweighted and weighted logistic regression models for nonresponse adjustments. Proceedings of the Survey Research Methods Section. American Statistical Association http://www.amstat.org/sections/srms/Proceedings/y2006f.html.
21. Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? - Some practical clarifications of multiple imputation theory. Prev Sci 2007, 8(3):206-213. 10.1007/s11121-007-0070-9, 17549635.
22. Menezes AM, Pérez-Padilla R, Hallal PC, Jardim JR, Muiño A, López MV, Valdivia G, Pertuze J, De Oca MM, Tálamo C. Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study. Int J Tuberc Lung Dis 2008, 12(7):709-12.
23. Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005, 60(10):842-7. 10.1136/thx.2005.043943, 1747202, 16085729.
24. Pérez-Padilla R, Hallal PC, Vázquez-García JC, Muiño A, Máquez M, López MV, De Oca MM, Tálamo C, Valdivia G, Pertuzé J, Jardim J, Menezes AM. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 2007, 4(2):113-20. 10.1080/15412550701341012, 17530504.
25. Shirtcliffe P, Weatherall M, Marsh S, Travers J, Hansell A, McNaughton A, Aldington S, Muellerova H, Beasley R. COPD prevalence in a random population survey: a matter of definition. Eur Respir J 2007, 30(2):232-9. 10.1183/09031936.00157906, 2516341, 17666557.
26. Vollmer WM, Enrigh PL, Buist AS, Gislason P, Burney P, Gulsvik A, Kocabas A. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009, 34(3):588-597. 10.1183/09031936.00164608, 3334278, 19460786.
27. Cerveri I, Corsico AG, Accordini S, Niniano R, Ansaldo E, Anto JM, Kunzli N, Janson C, Sunyer J, Jarvis D, Svanes C, Gislason T, Heinrich J, Schouten JP, Wjst M, Burney P, De Marco R. Underestimation of airflow obstruction among young adults using FEV(1)/FVC < 70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008, 63(12):1040-1045. 10.1136/thx.2008.095554, 18492741.
28. Menezes AM, Pérez-Padilla R, Jardim JB, Muiño A, López MV, Valdivia G, De Oca MM, Tálamo C, Hallal PC, Victora CG. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. LANCET 2005, 366(9500):1875-1881. 10.1016/S0140-6736(05)67632-5, 16310554.
29. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003, 58:388-393. 10.1136/thorax.58.5.388, 1746680, 12728157.
30. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006, 28(3):523-32. 10.1183/09031936.06.00124605, 16611654.